Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs.

Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs.

Find the latest Sage Therapeutics, Inc. (SAGE) stock quote, history, news and other vital information to help you with your stock trading and investing.

CAMBRIDGE, Mass., January 12, 2025 -- (BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that Chief Executive Officer Barry Greene will discuss the …

Jan 27, 2025 · After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on a range of strategic options. However, the company's …

It’s time to discover your future with Sage… We are Sage Therapeutics, and our vision is to fearlessly lead the way to create a world with better brain health. Why we believe life is more …

Nov 20, 2024 · Sage Therapeutics said on Wednesday it would stop the development of its experimental drug following the latest failure in a study testing it in patients with Huntington's …

Oct 18, 2023 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain …

Jan 27, 2025 · Sage Therapeutics Inc. is looking for a deal — but it’s not interested in the unsolicited acquisition offer it received earlier this month from longtime partner Biogen Inc.. …

Apr 16, 2010 · View SAGE Therapeutics, Inc. SAGE stock quote prices, financial information, real-time forecasts, and company news from CNN.